HSD19 Can Switching From Intravenous (IV) to Subcutaneous (SC) Formulations Save Time and Resources? A Service Impact Model (SIM)
Dec 1, 2025, 00:00
10.1016/j.jval.2025.09.1680
https://www.valueinhealthjournal.com/article/S1098-3015(25)04237-8/fulltext
Title :
HSD19 Can Switching From Intravenous (IV) to Subcutaneous (SC) Formulations Save Time and Resources? A Service Impact Model (SIM)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)04237-8&doi=10.1016/j.jval.2025.09.1680
First page :
Section Title :
Open access? :
No
Section Order :
11222